Objective: To estimate the excess burden of out-of-pocket health care spending associated with Alzheimer disease and related disorders (ADRD) among older individuals (age 65 y and older).
A lzheimer disease and related disorders (ADRD) affect 8.24% of individuals in the United States. 1 ADRD are associated with neurocognitive impairments due to its multiple etiologies, including Alzheimer disease, Lewy body disease, vascular disease, traumatic brain injury, HIV infection, prion disease, Parkinson disease, Huntington disease, and certain medications. Among ADRD, 80% of dementias are attributed to Alzheimer disease. 2 Individuals with ADRD may have worsening neurocognitive impairments as the disease progresses, often requiring increasing levels of medical and nonmedical care, including full-time residential services. Most elderly with Alzheimer disease are covered by Medicare because Medicare provides coverage for nearly all of the elderly in the United States. 3 However, not all health care expenditures are covered by Medicare. The patients and families bear some direct medical care costs in terms of deductibles, coinsurance, and copayments for medical care and prescription drugs, insurance premiums for supplemental coverage, amount paid for nonprescription medications; transportation to health care providers; and uncovered structural or lifestyle modifications. For example, among Medicare beneficiaries, health insurance premiums account for 42% of the total out-of-pocket spending, with payments toward cost-sharing and noncovered services and goods accounting for the remaining 58%. 3 In fact, the total payments for health care, long-term care, and hospice care are estimated to be $236 billion for people with ADRD in 2016, with just under half of the costs covered by Medicare. 4 Therefore, high out-of-pocket spending for ADRD care may place a significant financial burden on families draining resources for the household as a whole. 5 It is important to assess the magnitude of out-of-pocket expenditures because high expenditures can lead to worse health outcomes. For example, individuals with high out-of-pocket spending may stop taking their medications 6 and may not use preventive care or outpatient services for their health care in order to save money. 7, 8 This may exacerbate the ADRD symptoms and lead to higher rates of morbidity and mortality. 9 Furthermore, with disease progression, as individuals with ADRD face wor-sening medical complications and declining functional status, their mix of services required may vary. For example, it has been reported that nearly one-third (34.5%) used home health care and the incremental total costs for paid home care in 2010 was $5678, accounting for 20% of the incremental direct costs associated with ADRD. 10 These services may require copayments leading to high out-of-pocket expenses. Therefore, it is also important to examine out-of-pocket spending for different types of care such as home health, inpatient, outpatient, medical provider, and prescription drugs. This may also reflect the trade-off decisions patients need to make on the type of services when faced with limited financial resources.
However, only a few studies have evaluating the association between ADRD and out-of-pocket health care spending [10] [11] [12] [13] and these studies have limitations. Kelley et al 11 reported that the average out-of-pocket spending during the last 5-years of life for patients with dementia was 81% higher compared with patients without dementia. This study used Health Retirement Survey and included only fee-for-service Medicare beneficiaries (70 y and older) who died between 2005 and 2010. Hurd et al 10 used the same dataset and found that the average annual out-of-pocket spending can be as high as $6194 among elderly with ADRD. However, this study used an estimated probability of dementia rather than the observed status (yes/no). Delavande et al 12 compared individuals with normal cognition, dementia with cognitive impairment and dementia without cognitive impaired and reported that those with dementia and cognitive impairment had 356% higher annual out-of-pocket expenditures compared with those with normal cognition. This study did not analyze out-of-pocket spending burden as a percentage of income spent. Another study used the Medicare Current Beneficiary Survey (MCBS) and analyzed sex differences in life-time out-of-pocket spending. 13 However, that study included out-of-pocket spending only for assisted living facilities and home health care.
Therefore, the main objective of the current study is to estimate the excess burden of annual total direct out-of-pocket spending and out-of-pocket spending on different types of health care services among all community-dwelling elderly Medicare beneficiaries with ADRD by comparing them to those without ADRD.
CONCEPTUAL FRAMEWORK
The explanatory variables for this study were selected using the Andersen Expanded Behavioral Model. 14 Under this model, out-of-pocket expenditures of an individual is influenced by predisposition factors (eg, age, sex, and race), enabling factors (eg, marital status, education, and poverty status), need factors (eg, chronic conditions, health status), and personal health practices (eg, smoking, obesity, physical activity).
METHODS

Study Design
We adopted a retrospective cross-sectional design.
Data Source
The data source is the MCBS for the year 2012. The MCBS is nationally representative sample of Medicare beneficiaries-the aged, disabled and institutionalized. The survey began in 1992 and is released every year. The survey directly collects data from the respondents and includes selfreported health status, height and weight, activities of daily living, functional status, living arrangement, history of medical conditions, out-of-pocket expenditures, non-Medicare utilization, expenditures, and other health-related information. Data collected from the beneficiaries are merged with Medicare claims except for Part D through an extensive and rigorous reconciliation process. The survey is designed with a multistage, stratified, random sampling of Medicare beneficiaries. 4 West Virginia University Institutional Review Board reviewed this project and granted exemption status to the study as all the data were deidentified.
Study Sample
In this study, we restricted our sample to older adults (65 y and older), who lived in the community, who were alive, and enrolled in Medicare throughout the entire year. We excluded individuals who did not answer the relevant health questionnaires considered in our study (n = 158) and those who had zero total health care expenditures (n = 107). The final study sample included 7622 Medicare beneficiaries with (N = 462) or without ADRD (N = 7160).
Measures
Dependent Variables: Out-of-Pocket Health Care Spending
Out-of-pocket health care spending consisted of Medicare cost-sharing and noncovered services, but not insurance premiums. We examined out-of-pocket spending using several measures: absolute out-of-pocket expenditures; the log-transformed out-of-pocket spending; and out-of-pocket spending burden. We used log-transformed out-of-pocket expenditures, to reduce skewness 15, 16 Out-of-pocket spending burden was based on percent income spent out-of-pocket for health care. We defined an indicator of positive out-of-pocket spending, and an indicator of high out-of-pocket spending burden indicating that the percentage was above 10% of income based on prior studies. 17, 18 There were seven components of out-of-pocket spending which were considered in the analyses: home health, facility charges, hospice, inpatient, outpatient, medical provider, prescription drugs, and dental care. The out-of-pocket spending was measured over a 1-year period in 2012.
Key Independent Variable: Alzheimer's' Disease and Related Dementias (ADRD)
The key explanatory variable in our study was the presence or absence of ADRD. ADRD was ascertained using self-reports or Medicare claims. Self-reported ADRD was based on giving an affirmative response to either of the following 2 questions: "Has a doctor (ever) told [you/(SP)] that (you/he/she) had Alzheimer disease?" and "Has a doctor (ever) told [(you/(SP)] that (you/he/she) had any type of dementia other than Alzheimer disease?". We used the International Classification of Diseases, ninth edition Clinical Modification (ICD-9-CM) codes to derive ADRD from Medicare claims. The ICD-9-CM codes (including 3310, 33111, 33119, 3312, 3317, 2900, 29010, 29011, 29012, 29013, 29020, 29021, 2903, 29040, 29041, 29042, 29043, 2940, 29410, 29411, 29420, 29421, 2948, and 797). These codes were based on the Centers for Medicaid and Medicare Services (CMS) chronic conditions warehouse algorithm. 19 
Other Explanatory Variables
Using the Andersen Model health care utilization model, we identified predisposing characteristics consisting of sex (male/female), age (65-69, 70-74, 75-79, and 80 y and older), race/ethnicity (white, African American, Latino, other), enabling factors comprising marital status (married, widowed, divorced/ separated, or never married), education (less than high school, high school, or above high school, college), income relative to the federal poverty line (FPL) (< 200% of FPL or at least 200% of FPL), supplementary health insurance Medicaid (yes/no), private insurance (yes/ no), and prescription drug coverage (yes/no), and need factors: number of chronic conditions (considered from the following list: arthritis, cancer, diabetes, heart disease, hypertension, respiratory disease, osteoporosis, mental illness) (none, 1, 2-3, 4 or more), individual perceived health status (excellent, very good, good, fair, poor), functional limitations measured by activities of daily living (none, 1-2, 3 or more). We also adjusted for personal health practice factors, including body mass index (BMI) (underweight, normal weight, overweight, or obese), and smoking status (neversmoker, former smoker, or current smoker). The BMI categories were based on the CDC definition: underweight (< 18.5), normal (18.5-< 25), overweight (25.0-< 30), and obese (30.0 or higher). We also accounted for external environment such as socioeconomic status which included region of residence (Northeast, Midwest, South, and West), urban/rural status (metropolitan area/nonmetropolitan area) and income relative to the federal poverty level (< 200% of federal poverty level or at least 200% of federal poverty level). It has to be noted that all our independent variables were measured as categorical variables.
Statistical Analyses
We tested statistically significant differences between ADRD and no ADRD groups with χ 2 statistics. We used ordinary least squares for out-of-pocket spending in the whole sample and among those with positive out-of-pocket spending.
We conducted logistic regressions to examine the relationship between ADRD and having out-of-pocket spending burden above 10%. All our multivariable models adjusted for expanding number of covariates.
RESULTS
The sample consisted of 57% female, and 79% white. The age groups were equally distributed with 24% between 65 and 69 years, 27% were between 70 and 74 years, 20% between 75 and 79 years, and 30% at least 80 years of age (Table 1) .
There were significant group differences involving ADRD status and sex, race, age, marital status, poverty status, 
Unadjusted Differences in Out-of-Pocket Expenditures by ADRD Status
The average out-of-pocket spending by type of services and ADRD status are presented in Table 2 . Elderly with ADRD had significantly higher out-of-pocket spending across all measures except dental care. The total out-of-pocket spending in ADRD group was $3284.6 whereas the total out-of-pocket spending in no-ADRD group was $1895.0. Among those who had positive out-of-pocket spending (ie, expenditures that the insurance did not cover), the results were similar (total out-ofpocket spending was $3319.40 in ADRD group vs. $1907.20 in no-ADRD group), except the difference in outpatient spending became insignificant. Results for out-of-pocket spending burden is similar, however differences in outpatient, medical provider and dental spending failed to reach significance.
Adjusted Differences in Out-of-Pocket Expenditures by ADRD Status
On the basis of multivariable OLS regression on out-ofpocket spending (Table 3) , we observed that individuals with ADRD spent $1101 higher in total, $274 higher in prescription drugs (P < 0.01), $622 higher in home health (P < 0.05) than individuals without ADRD. Among those who had positive out-of-pocket spending, those with ADRD had substantially higher home health out-of-pocket spending ($5570) compared with individuals without ADRD. Individuals with ADRD also incurred higher out-of-pocket spending on prescription drugs ($274, P-value <0.001) and total out-of-pocket spending ($1126, P < 0.01). Individuals with ADRD spent less out-of-pocket on inpatient ($401, P-value <0.001) than individuals without ADRD.
In ordinary least squares estimation for log-transformed out-of-pocket spending analyses, individuals with ADRD had higher home health (β = 0.304 P < 0.01), prescription drugs, On the basis of 7622 Medicare beneficiaries age 65 and older, alive during the calendar and had positive total health care expenditures. Significant group differences average out-of-pocket spending by ADRD status were based on t tests. Among those with out-of-pocket spending greater than zero, the total spending is not sum of individual domains.
ADRD indicates Alzheimer disease and related disorders; Sig, significance; Wt, weighted. On the basis of 7622 Medicare beneficiaries age 65 and older, alive during the calendar and had positive total health care expenditures. The regression models controlled for sex, age, race/ethnicity, marital status, education, poverty status, Medicaid, private insurance, prescription drug coverage, number of chronic conditions, perceived physical health, functional status, body mass index, and current smoking.
ADRD indicates Alzheimer disease and related dementias; Prob, probability; Sig, significance.
(β = 0.498 P < 0.001), inpatient (β = 0.273 P < 0.01) and overall out-of-pocket spending (β = 0.319 P < 0.001) compared with those without ADRD.
Out-of-Pocket Spending Burden by ADRD Status
We also examined the out-of-pocket spending burden by ADRD status using percent income spent on health care services (Table 4) . Individuals with ADRD spent a significantly higher percentage of their income on medical services among those without ADRD (at 12% vs. 7%). They also spent a significantly higher percentage on home health, prescription drugs, and medical provider visits. Similar results were obtained using the ordinary least squares regression (eg, higher percentage of their income spent on home health, prescription drugs, and overall).
We examined the number and percentages of individuals with out-of-pocket spending burden above 10% (high out-of-pocket spending burden) ( Table 5 ). Individuals with ADRD were more likely to have spent > 10% of their income on health care (30% vs. 17%; P < 0.0001). We expanded the list of covariates adjusted in the model and found that although the adjusted odds ratio were attenuated, a significant association of ADRD and higher out-of-pocket remained in the model (adjusted odds ratio, 1.49; 95% confidence interval, 1.13-1.97).
DISCUSSION
In unadjusted analyses, we found that having ADRD was associated with a doubling of total out-of-pocket spending over those without ADRD. Even after adjusting for other factors, those with ADRD had 37.5% higher On the basis of 7622 Medicare beneficiaries age 65 and older, alive during the calendar and had positive total health care expenditures. The regression models controlled for sex, age, race/ethnicity, marital status, education, poverty status, Medicaid, private insurance, prescription drug coverage, number of chronic conditions, perceived physical health, functional status, body mass index, and current smoking.
ADRD indicates Alzheimer disease and related dementias; Prob, probability; Sig, significance; Wt, weighted. On the basis of 7622 Medicare beneficiaries age 65 and older, alive during the calendar and had positive total health care expenditures. The regression models controlled for sex, age, race/ethnicity, marital status, education, poverty status, Medicaid, private insurance, prescription drug coverage, number of chronic conditions, perceived physical health, functional status, body mass index, and current smoking. High OOP spending burden is defined as spending > 10% of family income OOP for medical care.
ADRD indicates Alzheimer disease and related dementias; AOR, adjusted odds ratio; CI, confidence interval; OOP, out-of-pocket; Sig, significance; Wt, weighted.
*0.01 ≤ P < 0.05. ** 0.001 ≤ P < 0.01. *** P < 0.001.
out-of-pocket spending compared with those without ADRD. The care of individuals with ADRD is complex because the care includes increasing dependency on others for basic daily care needs, the management of comorbid conditions and the need for appropriate end-of-life care. 20 Their range of needs span from minor assistance at the outset of the dementia to comprehensive services to meet activities of daily living and other care to address issues from the disease progression or other co-morbidities. The usual course of the disease is 5-10 years with the majority of the care focused on keeping the individual in community rather than a nursing facility. We are not able to directly compare our estimates of out-of-pocket spending on health care with published studies due to differences in samples, time period, and components of out-of-pocket spending. However, when examined as proportions, our estimates were considerably smaller (73%) compared with the 356% higher out-of-pocket spending reported by Delavande et al. 12 We speculate that our estimates are lower because our study sample included elderly who were living in the community and did not include nursing home spending. It has to be noted that our finding of higher out-of-pocket spending among individuals with ADRD is contrary to the published study by Delavande et al, 21 who found no significant differences among those with dementia and cognitive impairment or normal cognition.
In our study, we found higher levels of out-of-pocket spending on home health care among those with ADRD compared with elderly without ADRD. This was not unexpected because home health is an important component of overall health management as this level of care often provides some assistance with self-care and opportunities for social engagement for the person with dementia and prevents behavioral outbursts, falls, injuries, or individuals from getting lost while the individual is receiving skilled nursing care. The increased utilization of home health and other skilled care has been noted in other studies, particularly in Lin et al, 22 where they found, when compared with matched controls, individuals with ADRD were shown to use more home health before and after diagnosis. These authors concluded that recognition of the ADRD diagnosis takes special attention, It is worth noting that there is a recognition of the impact of the ADRD crisis by the policy-makers at the US Department of Health and Human Services who created the National Plan to Address Alzheimer Disease to assist family members and persons with ADRD through research, care, and governmental collaboration. 23 We observed that elderly with ADRD had higher outof-pocket spending on prescription drugs compared with those without ADRD, consisted with prior studies. 24 The cost of prescription medications are on the rise in the United States In 2016, the total US prescription sales were $448.2 billion, a 5.8% increase compared with 2015. Prescription expenditures in clinics and nonfederal hospitals totaled $63.7 billion (an 11.9% increase from 2015) and $34.5 billion (a 3.3% increase from 2015), respectively. 25 This increase may disproportionately impact those with ADRD because they have higher number of multiple chronic conditions that require medications compared with patients without ADRD, which has been observed in our study as well as other published studies. 24 Multimorbidity and polypharmacy complicate the needs of persons with ADRD and may also result in potentially inappropriate medications, adverse events from medications, both of which may also increase the out-of-pocket costs for these patients with ADRD. 26 Another contributing factor to increased levels of outof-pocket expenditures for those with ADRD is the presence of the "donut-hole" gap (ie, prescription drug coverage gap) in Medicare coverage. Patients with ADRD are particularly vulnerable to this gap; 39.5% of patients with ADRD experienced "donut-hole," which may partially explain the high out-of-pocket. 27 These findings have implications for clinical management of chronic conditions. Although not specific to ADRD, a systematic review of cost-sharing for prescription drugs found that in 85% of the studies cost-sharing for prescription drugs had a negative effect on adherence. 28 The same review indicated that many studies (86% of the total studies reviewed) found improved adherence to be associated with improved health outcomes, suggesting that cost-sharing may lead to poor health outcomes. 28 Given that the number of older Americans with ADRD will likely increase significantly in the future, changes in public funding and health care policy aimed at reducing out-of-pocket spending for can reduce the financial burden of individuals with ADRD and their families. It is estimated that a tax credit for insured Americans who spent > 5% of their income on health care can decrease spending up to 33%. 29 Setting copays based on the level of sickness such as those adopted in France can also be considered. [30] [31] [32] As cost-sharing is a major barrier for chronic care, 33 waiving or reducing cost-sharing for those with chronic illnesses such as ADRD may not only decrease the financial burden on the patients and their families but also improve chronic illness care.
Study Limitations
Several limitations to our study should be noted. Misclassification bias is possible with MCBS data. MCBS may not have captured all of the individuals with ADRD since, as a medical claims data source, if individuals have not sought care for ADRD, they would not have been identified as having ADRD. We could not measure the severity of ADRD as MCBS did not collect severity information. Also, some components of treatments may not be included in charges (and therefore not in the claims data) if reimbursement rates are very low, even if the treatment is provided or if out-of-pocket costs resulted. Medicare's home health care benefit is limited. Medicare does not cover 24-hour care at home, meals delivered to the individual's home, and homemaker or custodial care services (ie, cooking, shopping, and laundry) unless such care is part of the skilled nursing or skilled therapy services individuals receive from a home health aide. 34 Finally, income and asset data are not available for people with ADRD in MCBS dataset.
Considerations for Future Research
Individuals with ADRD often have family members or significant others provide uncompensated care. It is estimated that informal caregivers provide 70 hours per week to individuals with ADRD 35, 36 Caregivers often experience lost earnings as a result 37, 38 The Alzheimer's Association reported 17.4 billion hours of unpaid care was provided for individuals with ADRD in 2011, valued at $210 billion. 39 In addition, > 60% of formal services provided for individuals with ADRD are financed by the family, regardless of care setting. 35 The growing elderly population and the possible shortage of informal caregivers increase individuals' health care needs and costs. 40 Policymakers recommend that people plan and save for the likelihood of requiring long-term care, and that tax proposals should be in place to limit the financial burdens.
Additional research is needed to examine caregiver burden including the extent to which individuals are providing care to those with ADRD, the nature of the care that is being provided, the impact on the family psychosocially by providing the care, and the impact on the family financially. Previously most of the research has focused upon the person with ADRD, additional information is needed about the impact more broadly.
CONCLUSIONS
Medicare beneficiaries with ADRD have higher out-ofpocket expenditures as compared with Medicare beneficiaries without ADRD. The financial burden as a percent of income is higher with Medicare beneficiaries with ADRD as compared with Medicare beneficiaries without ADRD.
